Global Low-density Lipoprotein Apheresis Therapy Market Research Report 2023

The global Low-density Lipoprotein Apheresis Therapy market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Low-density Lipoprotein Apheresis Therapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Low-density Lipoprotein Apheresis Therapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Low-density Lipoprotein Apheresis Therapy in Atherosclerosis Patient is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Low-density Lipoprotein Apheresis Therapy include Kaneka Pharma, B.Braun, Fresenius Medical Care, Asahi Kasei Medical, Medicap, Kawasumi Laboratories, Terumo Corporation and Haemonetics, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Low-density Lipoprotein Apheresis Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Low-density Lipoprotein Apheresis Therapy.

The Low-density Lipoprotein Apheresis Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Low-density Lipoprotein Apheresis Therapy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Low-density Lipoprotein Apheresis Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Double Filtration LDL Apheresis Therapy

1.2.3 Cascade Filtration LDL Apheresis Therapy

1.3 Market by Application

1.3.1 Global Low-density Lipoprotein Apheresis Therapy Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Atherosclerosis Patient

1.3.3 Obesity Patient

1.3.4 Dyslipidemia Patient

1.3.5 Coronary Heart Disease Patient

1.3.6 Carotid Artery Disease Patient

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Low-density Lipoprotein Apheresis Therapy Market Perspective (2018-2029)

2.2 Low-density Lipoprotein Apheresis Therapy Growth Trends by Region

2.2.1 Global Low-density Lipoprotein Apheresis Therapy Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Low-density Lipoprotein Apheresis Therapy Historic Market Size by Region (2018-2023)

2.2.3 Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Region (2024-2029)

2.3 Low-density Lipoprotein Apheresis Therapy Market Dynamics

2.3.1 Low-density Lipoprotein Apheresis Therapy Industry Trends

2.3.2 Low-density Lipoprotein Apheresis Therapy Market Drivers

2.3.3 Low-density Lipoprotein Apheresis Therapy Market Challenges

2.3.4 Low-density Lipoprotein Apheresis Therapy Market Restraints

3.1 Global Top Low-density Lipoprotein Apheresis Therapy Players by Revenue

3.1.1 Global Top Low-density Lipoprotein Apheresis Therapy Players by Revenue (2018-2023)

3.1.2 Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share by Players (2018-2023)

3.2 Global Low-density Lipoprotein Apheresis Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Low-density Lipoprotein Apheresis Therapy Revenue

3.4 Global Low-density Lipoprotein Apheresis Therapy Market Concentration Ratio

3.4.1 Global Low-density Lipoprotein Apheresis Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Low-density Lipoprotein Apheresis Therapy Revenue in 2022

3.5 Low-density Lipoprotein Apheresis Therapy Key Players Head office and Area Served

3.6 Key Players Low-density Lipoprotein Apheresis Therapy Product Solution and Service

3.7 Date of Enter into Low-density Lipoprotein Apheresis Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Low-density Lipoprotein Apheresis Therapy Historic Market Size by Type (2018-2023)

4.2 Global Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Type (2024-2029)

5.1 Global Low-density Lipoprotein Apheresis Therapy Historic Market Size by Application (2018-2023)

5.2 Global Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Application (2024-2029)

6.1 North America Low-density Lipoprotein Apheresis Therapy Market Size (2018-2029)

6.2 North America Low-density Lipoprotein Apheresis Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2018-2023)

6.4 North America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Low-density Lipoprotein Apheresis Therapy Market Size (2018-2029)

7.2 Europe Low-density Lipoprotein Apheresis Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Low-density Lipoprotein Apheresis Therapy Market Size by Country (2018-2023)

7.4 Europe Low-density Lipoprotein Apheresis Therapy Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size (2018-2029)

8.2 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Region (2018-2023)

8.4 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Low-density Lipoprotein Apheresis Therapy Market Size (2018-2029)

9.2 Latin America Low-density Lipoprotein Apheresis Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2018-2023)

9.4 Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size (2018-2029)

10.2 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size by Country (2018-2023)

10.4 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Kaneka Pharma

11.1.1 Kaneka Pharma Company Detail

11.1.2 Kaneka Pharma Business Overview

11.1.3 Kaneka Pharma Low-density Lipoprotein Apheresis Therapy Introduction

11.1.4 Kaneka Pharma Revenue in Low-density Lipoprotein Apheresis Therapy Business (2018-2023)

11.1.5 Kaneka Pharma Recent Development

11.2 B.Braun

11.2.1 B.Braun Company Detail

11.2.2 B.Braun Business Overview

11.2.3 B.Braun Low-density Lipoprotein Apheresis Therapy Introduction

11.2.4 B.Braun Revenue in Low-density Lipoprotein Apheresis Therapy Business (2018-2023)

11.2.5 B.Braun Recent Development

11.3 Fresenius Medical Care

11.3.1 Fresenius Medical Care Company Detail

11.3.2 Fresenius Medical Care Business Overview

11.3.3 Fresenius Medical Care Low-density Lipoprotein Apheresis Therapy Introduction

11.3.4 Fresenius Medical Care Revenue in Low-density Lipoprotein Apheresis Therapy Business (2018-2023)

11.3.5 Fresenius Medical Care Recent Development

11.4 Asahi Kasei Medical

11.4.1 Asahi Kasei Medical Company Detail

11.4.2 Asahi Kasei Medical Business Overview

11.4.3 Asahi Kasei Medical Low-density Lipoprotein Apheresis Therapy Introduction

11.4.4 Asahi Kasei Medical Revenue in Low-density Lipoprotein Apheresis Therapy Business (2018-2023)

11.4.5 Asahi Kasei Medical Recent Development

11.5 Medicap

11.5.1 Medicap Company Detail

11.5.2 Medicap Business Overview

11.5.3 Medicap Low-density Lipoprotein Apheresis Therapy Introduction

11.5.4 Medicap Revenue in Low-density Lipoprotein Apheresis Therapy Business (2018-2023)

11.5.5 Medicap Recent Development

11.6 Kawasumi Laboratories

11.6.1 Kawasumi Laboratories Company Detail

11.6.2 Kawasumi Laboratories Business Overview

11.6.3 Kawasumi Laboratories Low-density Lipoprotein Apheresis Therapy Introduction

11.6.4 Kawasumi Laboratories Revenue in Low-density Lipoprotein Apheresis Therapy Business (2018-2023)

11.6.5 Kawasumi Laboratories Recent Development

11.7 Terumo Corporation

11.7.1 Terumo Corporation Company Detail

11.7.2 Terumo Corporation Business Overview

11.7.3 Terumo Corporation Low-density Lipoprotein Apheresis Therapy Introduction

11.7.4 Terumo Corporation Revenue in Low-density Lipoprotein Apheresis Therapy Business (2018-2023)

11.7.5 Terumo Corporation Recent Development

11.8 Haemonetics

11.8.1 Haemonetics Company Detail

11.8.2 Haemonetics Business Overview

11.8.3 Haemonetics Low-density Lipoprotein Apheresis Therapy Introduction

11.8.4 Haemonetics Revenue in Low-density Lipoprotein Apheresis Therapy Business (2018-2023)

11.8.5 Haemonetics Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Double Filtration LDL Apheresis Therapy

    Table 3. Key Players of Cascade Filtration LDL Apheresis Therapy

    Table 4. Global Low-density Lipoprotein Apheresis Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Low-density Lipoprotein Apheresis Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Low-density Lipoprotein Apheresis Therapy Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Low-density Lipoprotein Apheresis Therapy Market Share by Region (2018-2023)

    Table 8. Global Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Low-density Lipoprotein Apheresis Therapy Market Share by Region (2024-2029)

    Table 10. Low-density Lipoprotein Apheresis Therapy Market Trends

    Table 11. Low-density Lipoprotein Apheresis Therapy Market Drivers

    Table 12. Low-density Lipoprotein Apheresis Therapy Market Challenges

    Table 13. Low-density Lipoprotein Apheresis Therapy Market Restraints

    Table 14. Global Low-density Lipoprotein Apheresis Therapy Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Low-density Lipoprotein Apheresis Therapy Market Share by Players (2018-2023)

    Table 16. Global Top Low-density Lipoprotein Apheresis Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Low-density Lipoprotein Apheresis Therapy as of 2022)

    Table 17. Ranking of Global Top Low-density Lipoprotein Apheresis Therapy Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Low-density Lipoprotein Apheresis Therapy Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Low-density Lipoprotein Apheresis Therapy Product Solution and Service

    Table 21. Date of Enter into Low-density Lipoprotein Apheresis Therapy Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Low-density Lipoprotein Apheresis Therapy Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share by Type (2018-2023)

    Table 25. Global Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share by Type (2024-2029)

    Table 27. Global Low-density Lipoprotein Apheresis Therapy Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share by Application (2018-2023)

    Table 29. Global Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share by Application (2024-2029)

    Table 31. North America Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Low-density Lipoprotein Apheresis Therapy Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Low-density Lipoprotein Apheresis Therapy Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Kaneka Pharma Company Detail

    Table 47. Kaneka Pharma Business Overview

    Table 48. Kaneka Pharma Low-density Lipoprotein Apheresis Therapy Product

    Table 49. Kaneka Pharma Revenue in Low-density Lipoprotein Apheresis Therapy Business (2018-2023) & (US$ Million)

    Table 50. Kaneka Pharma Recent Development

    Table 51. B.Braun Company Detail

    Table 52. B.Braun Business Overview

    Table 53. B.Braun Low-density Lipoprotein Apheresis Therapy Product

    Table 54. B.Braun Revenue in Low-density Lipoprotein Apheresis Therapy Business (2018-2023) & (US$ Million)

    Table 55. B.Braun Recent Development

    Table 56. Fresenius Medical Care Company Detail

    Table 57. Fresenius Medical Care Business Overview

    Table 58. Fresenius Medical Care Low-density Lipoprotein Apheresis Therapy Product

    Table 59. Fresenius Medical Care Revenue in Low-density Lipoprotein Apheresis Therapy Business (2018-2023) & (US$ Million)

    Table 60. Fresenius Medical Care Recent Development

    Table 61. Asahi Kasei Medical Company Detail

    Table 62. Asahi Kasei Medical Business Overview

    Table 63. Asahi Kasei Medical Low-density Lipoprotein Apheresis Therapy Product

    Table 64. Asahi Kasei Medical Revenue in Low-density Lipoprotein Apheresis Therapy Business (2018-2023) & (US$ Million)

    Table 65. Asahi Kasei Medical Recent Development

    Table 66. Medicap Company Detail

    Table 67. Medicap Business Overview

    Table 68. Medicap Low-density Lipoprotein Apheresis Therapy Product

    Table 69. Medicap Revenue in Low-density Lipoprotein Apheresis Therapy Business (2018-2023) & (US$ Million)

    Table 70. Medicap Recent Development

    Table 71. Kawasumi Laboratories Company Detail

    Table 72. Kawasumi Laboratories Business Overview

    Table 73. Kawasumi Laboratories Low-density Lipoprotein Apheresis Therapy Product

    Table 74. Kawasumi Laboratories Revenue in Low-density Lipoprotein Apheresis Therapy Business (2018-2023) & (US$ Million)

    Table 75. Kawasumi Laboratories Recent Development

    Table 76. Terumo Corporation Company Detail

    Table 77. Terumo Corporation Business Overview

    Table 78. Terumo Corporation Low-density Lipoprotein Apheresis Therapy Product

    Table 79. Terumo Corporation Revenue in Low-density Lipoprotein Apheresis Therapy Business (2018-2023) & (US$ Million)

    Table 80. Terumo Corporation Recent Development

    Table 81. Haemonetics Company Detail

    Table 82. Haemonetics Business Overview

    Table 83. Haemonetics Low-density Lipoprotein Apheresis Therapy Product

    Table 84. Haemonetics Revenue in Low-density Lipoprotein Apheresis Therapy Business (2018-2023) & (US$ Million)

    Table 85. Haemonetics Recent Development

    Table 86. Research Programs/Design for This Report

    Table 87. Key Data Information from Secondary Sources

    Table 88. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Low-density Lipoprotein Apheresis Therapy Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Low-density Lipoprotein Apheresis Therapy Market Share by Type: 2022 VS 2029

    Figure 3. Double Filtration LDL Apheresis Therapy Features

    Figure 4. Cascade Filtration LDL Apheresis Therapy Features

    Figure 5. Global Low-density Lipoprotein Apheresis Therapy Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Low-density Lipoprotein Apheresis Therapy Market Share by Application: 2022 VS 2029

    Figure 7. Atherosclerosis Patient Case Studies

    Figure 8. Obesity Patient Case Studies

    Figure 9. Dyslipidemia Patient Case Studies

    Figure 10. Coronary Heart Disease Patient Case Studies

    Figure 11. Carotid Artery Disease Patient Case Studies

    Figure 12. Low-density Lipoprotein Apheresis Therapy Report Years Considered

    Figure 13. Global Low-density Lipoprotein Apheresis Therapy Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Low-density Lipoprotein Apheresis Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Low-density Lipoprotein Apheresis Therapy Market Share by Region: 2022 VS 2029

    Figure 16. Global Low-density Lipoprotein Apheresis Therapy Market Share by Players in 2022

    Figure 17. Global Top Low-density Lipoprotein Apheresis Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Low-density Lipoprotein Apheresis Therapy as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Low-density Lipoprotein Apheresis Therapy Revenue in 2022

    Figure 19. North America Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Low-density Lipoprotein Apheresis Therapy Market Share by Country (2018-2029)

    Figure 21. United States Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Low-density Lipoprotein Apheresis Therapy Market Share by Country (2018-2029)

    Figure 25. Germany Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Share by Region (2018-2029)

    Figure 33. China Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Low-density Lipoprotein Apheresis Therapy Market Share by Country (2018-2029)

    Figure 41. Mexico Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Share by Country (2018-2029)

    Figure 45. Turkey Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Kaneka Pharma Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2018-2023)

    Figure 48. B.Braun Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2018-2023)

    Figure 49. Fresenius Medical Care Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2018-2023)

    Figure 50. Asahi Kasei Medical Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2018-2023)

    Figure 51. Medicap Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2018-2023)

    Figure 52. Kawasumi Laboratories Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2018-2023)

    Figure 53. Terumo Corporation Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2018-2023)

    Figure 54. Haemonetics Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2018-2023)

    Figure 55. Bottom-up and Top-down Approaches for This Report

    Figure 56. Data Triangulation

    Figure 57. Key Executives Interviewed